1. Home
  2. PULM vs NWGL Comparison

PULM vs NWGL Comparison

Compare PULM & NWGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PULM
  • NWGL
  • Stock Information
  • Founded
  • PULM 2003
  • NWGL 2008
  • Country
  • PULM United States
  • NWGL Macau
  • Employees
  • PULM N/A
  • NWGL N/A
  • Industry
  • PULM Biotechnology: Pharmaceutical Preparations
  • NWGL
  • Sector
  • PULM Health Care
  • NWGL
  • Exchange
  • PULM Nasdaq
  • NWGL Nasdaq
  • Market Cap
  • PULM 33.2M
  • NWGL 26.2M
  • IPO Year
  • PULM N/A
  • NWGL 2023
  • Fundamental
  • Price
  • PULM $6.20
  • NWGL $1.02
  • Analyst Decision
  • PULM
  • NWGL
  • Analyst Count
  • PULM 0
  • NWGL 0
  • Target Price
  • PULM N/A
  • NWGL N/A
  • AVG Volume (30 Days)
  • PULM 59.3K
  • NWGL 783.7K
  • Earning Date
  • PULM 08-12-2025
  • NWGL 07-22-2025
  • Dividend Yield
  • PULM N/A
  • NWGL N/A
  • EPS Growth
  • PULM N/A
  • NWGL N/A
  • EPS
  • PULM N/A
  • NWGL N/A
  • Revenue
  • PULM $1,921,000.00
  • NWGL $21,539,347.00
  • Revenue This Year
  • PULM N/A
  • NWGL N/A
  • Revenue Next Year
  • PULM $134.88
  • NWGL N/A
  • P/E Ratio
  • PULM N/A
  • NWGL N/A
  • Revenue Growth
  • PULM N/A
  • NWGL N/A
  • 52 Week Low
  • PULM $1.78
  • NWGL $0.91
  • 52 Week High
  • PULM $10.40
  • NWGL $6.61
  • Technical
  • Relative Strength Index (RSI)
  • PULM 41.72
  • NWGL 44.72
  • Support Level
  • PULM $6.28
  • NWGL $0.98
  • Resistance Level
  • PULM $6.83
  • NWGL $1.07
  • Average True Range (ATR)
  • PULM 0.44
  • NWGL 0.11
  • MACD
  • PULM -0.05
  • NWGL -0.03
  • Stochastic Oscillator
  • PULM 13.89
  • NWGL 19.09

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

Share on Social Networks: